Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response

Molecular Cancer Therapeutics
Kathleen I PishasStephen L Lessnick

Abstract

Multi-agent chemotherapeutic regimes remain the cornerstone treatment for Ewing sarcoma, the second most common bone malignancy diagnosed in pediatric and young adolescent populations. We have reached a therapeutic ceiling with conventional cytotoxic agents, highlighting the need to adopt novel approaches that specifically target the drivers of Ewing sarcoma oncogenesis. As KDM1A/lysine-specific demethylase 1 (LSD1) is highly expressed in Ewing sarcoma cell lines and tumors, with elevated expression levels associated with worse overall survival (P = 0.033), this study has examined biomarkers of sensitivity and mechanisms of cytotoxicity to targeted KDM1A inhibition using SP-2509 (reversible KDM1A inhibitor). We report, that innate resistance to SP-2509 was not observed in our Ewing sarcoma cell line cohort (n = 17; IC50 range, 81 -1,593 nmol/L), in contrast resistance to the next-generation KDM1A irreversible inhibitor GSK-LSD1 was observed across multiple cell lines (IC50 > 300 μmol/L). Although TP53/STAG2/CDKN2A status and basal KDM1A mRNA and protein levels did not correlate with SP-2509 response, induction of KDM1B following SP-2509 treatment was strongly associated with SP-2509 hypersensitivity. We show that the transcript...Continue Reading

References

Dec 20, 2003·Cell Death and Differentiation·S Oyadomari, M Mori
Aug 12, 2006·The Journal of Biological Chemistry·Sanjay AdhikariRabindra Roy
Sep 6, 2006·EMBO Reports·Eva SzegezdiAfshin Samali
Feb 26, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Karl-Ludwig SchaeferChristopher Poremba
May 2, 2009·The Journal of Biological Chemistry·Aristotele KarytinosAndrea Mattevi
Feb 19, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Cristina ZibettiElena Battaglioli
Mar 2, 2010·European Journal of Cell Biology·Shuang LvXingzhi Xu
Jan 27, 2011·Methods in Enzymology·Karen CawleySanjeev Gupta
Sep 20, 2011·Clinical Epigenetics·Emily L Putiri, Keith D Robertson
Jan 31, 2012·Cancer Research·J Chad BrennerArul M Chinnaiyan
Feb 14, 2012·Nature Genetics·Sophie Postel-VinayOlivier Delattre
Aug 8, 2012·Molecular Cancer·Francesco CreaCheryl D Helgason
Jun 12, 2013·Biochemical and Biophysical Research Communications·Yanyan YuDongfeng Chen
Jan 31, 2014·Nature·UNKNOWN Cancer Genome Atlas Research Network
Jun 26, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Savita SankarStephen L Lessnick
Sep 5, 2014·Cancer Discovery·Brian D CromptonKimberly Stegmaier
Feb 18, 2015·BioMed Research International·Roumiana Todorova
May 10, 2015·Journal of Ovarian Research·Cong ChenXuefeng Fang
Aug 1, 2015·Journal of Cell Science·Allana SchooleyWolfram Antonin
Aug 5, 2015·International Journal of Cancer. Journal International Du Cancer·Keisuke KosumiHideo Baba
Feb 6, 2016·Oncotarget·Emily R TheisenStephen L Lessnick
Feb 9, 2016·Nature Medicine·Himisha BeltranFrancesca Demichelis
Sep 17, 2016·F1000Research·Kathleen I Pishas, Stephen L Lessnick
Feb 24, 2017·Cell Death & Disease·Josefina CastexThomas Günther

❮ Previous
Next ❯

Citations

Jun 18, 2019·Pediatric Blood & Cancer·Antonio Romo-MoralesJanet M Shipley
Jun 25, 2019·Oncotarget·Priyal O PatelStephen L Lessnick
Jan 9, 2019·Frontiers in Oncology·Eva De SmedtElke De Bruyne
Feb 23, 2020·Case Reports in Oncological Medicine·Binoy Yohannan, Mark Feldman
Aug 28, 2020·Epigenetics : Official Journal of the DNA Methylation Society·Emily R TheisenStephen L Lessnick
Dec 19, 2018·Oncotarget·Kathleen I Pishas, Stephen L Lessnick
Aug 6, 2020·Therapeutic Advances in Medical Oncology·Wen PengYinglan Zhao
Sep 30, 2020·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Andrew Dj PearsonGilles Vassal
Aug 24, 2020·Bone·Filomena de NigrisClaudio Napoli
Jan 27, 2021·The New England Journal of Medicine·Nicolò RiggiIvan Stamenkovic
Jun 27, 2021·Experimental Biology and Medicine·Xuyang HouDaming Li
Aug 10, 2021·Biochimica Et Biophysica Acta. Reviews on Cancer·Fan TangXia-Wei Wei
Oct 19, 2021·PLoS Computational Biology·Davis T WeaverJacob G Scott
Sep 2, 2021·Molecular Cancer Research : MCR·Megann A BooneMark Winstanley
Dec 21, 2021·ACS Pharmacology & Translational Science·Natalia SacilottoRobert Soliva

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.